 |
Printer Friendly
Printed from http://www.researchandmarkets.com/reports/44928
Analysis of Prostate Cancer R&D: The Complete Guide
|
Description: |
Analysis of Prostate Cancer R&D - the Complete Guide offers a unique tool for analysing the vast amount of strategic possibilities that have emerged in prostate cancer R&D. It is at the same time a map of the research and development, a history of the achievments up to date, and a guide pointing out the directions of the future.
This tool provides you with an immense amount of information structured and analysed to assist you in your work.
Our hope is that this product will assist you in your struggle of finding the right partners, optimizing your licensing deals, wisely choosing which projects give you the best competitive advantage, and assuring you that your decisions have been based on the most accurate, validated and precise facts available.
For your conveniance, information about new innovative cancer therapies such as antisense, monoclonal antibodies, gene therapy, antigen- or cellular-based vaccines, liposomal hormones and apoptotic drugs are analyzed in more than 100 extensive tables and graphs. "Analysis of Prostate Cancer R&D - the Complete Guide" gives you easy-to-read tables with projects classified into well-defined structures based on type of therapy given, effect and mechanism. The graphs provide all the relations of these factors as well as the general and specific trends in the current prostate cancer pipeline.
Included in this advantageous package are two products already appreciated by many of our customers representing a value of almost $5000 - the Global Structure of Prostate Cancer R&D and the Prostate Cancer R&D database. The package includes:
-Information on more that 160 companies active in prostate cancer R&D
-Information on more that 300 industry related prostate cancer projects
-Data from 170 clinical trials
-Information on more than 130 preclinical projects
-92 graphs illustrating the most important relations between types of therapy, effects and mecanisms
-Advanced analysis of general and specific trends in the pipeline
-Possibility of performing advanced searches suited to your individual needs
Taking these searches a step further by generating specific and relevant tables and graphs for optimized support in your decision-making process
|
|
Summary: |
In Europe and the US there are close to 20 million people that live with cancer today, a figure that is increasing. 6.2 million people worldwide died of cancer in 1998. The American Cancer Society estimates that approximately 1.2 million new cancer cases were diagnosed in the year 2000 in the US. Overall annual costs associated with cancer currently amount to $107 billion in the United States alone. The worldwide anti-cancer market was valued at more than $15 billion in 1998 and is projected to nearly double by 2003. Approximately 30% of all collaborative deals are signed in the field of cancer.
According to the American Cancer Society, after skin cancer, prostate cancer is the most common type of cancer found in American men and is the second leading cause of cancer deaths in men, exceeded only by lung cancer. In 2003, there will be an estimated 221 000 new cases of prostate cancer in the United States, and about 29 000 men will die of the disease.
This report will assist you in:
-Tracking cutting edge companies, therapies and new technologies
-Rapid identification of partners & competitors
-Laying down a comprehensive framework for further analysis of the field
-Producing presentations surrounding the development of prostate cancer therapeutics
-Identifying emerging prostate cancer products & key areas of pharmaceutical R&D
|
|
Companies Mentioned |
Some of the companies analysed in this report include:
-Abbott Laboratories
-AEterna Laboratories
-Alfacell
-AlphaVax
-ALZA
-Aronex Pharmaceuticals
-AstraZeneca
-Aventis
-AVI BioPharma
-Baxter
-Biogen
-BioVex
-Bristol-Myers Squibb Co
-Celera Genomics
-Celgene
-Cell Therapeutics
-CellGenix
-Cephalon
-Corautus
-Corixa
-Coulter Pharmaceutical
-Cytel
-Dendreon
-Eli Lilly & Co
-F Hoffmann-La Roche
-Fujisawa Pharmaceutical
-Genentech
-GlaxoSmithKline
-GTx
-Hybridon
-IDEC Pharma
-ILEX Oncology
-ImClone/BMS/Merck
-Immunex
-Immunomedics
-ISIS Pharmaceuticals
-Maxim Pharmaceuticals
-Medarex
-Millennium
-ML Laboratories
-Novogen
-Oncology Sciences
-Paladin Labs
-Pfizer
-Pharmacia
-PSMA Development Company (PDC)
-Roche Holding
-Seattle Genetics
-Takeda Chemical Industries
-Transgene
-Wyeth Pharmaceuticals
-Yamanouchi Pharmaceutical Co
-YM Biosciences
|
|
Ordering: |
Order Online - visit http://www.researchandmarkets.com/reports/44928
Order by Fax - using the order form below
Order By Post - print the order form below and send to
|
|
Research and Markets,
Guinness Centre,
Taylors Lane,
Dublin 8,
Ireland.
|
|
|
 |
Page 1 of 2
Printed 28/11/2009 19:19:51 |
|
Fax Order Form
To place an order via fax simply print this form, fill in the information below and
fax the completed form to
646-607-1907 (from USA) or +353 1 6849977 (from Rest of World). If you have any questions please email help@researchandmarkets.net
Order information
Please verify that the product information is correct and select the format you require.
|
|
|
|
Product Name: |
Analysis of Prostate Cancer R&D: The Complete Guide
|
|
Web Address: |
http://www.researchandmarkets.com/reports/44928
|
|
Office Code: |
|
OC8HJNPOUMUXU
|
Report formats
Please enter the quantity of the report format you require.
|
|
Format
|
Quantity
|
Price
|
|
Electronic
|
|
€2,750.00
|
Contact information
Please enter all the information below in BLOCK CAPITALS.
|
|
|
First Name: |
Last Name: |
|
Email Address: |
|
|
Job Title: |
|
|
Organisation: |
|
|
Address: |
|
|
City: |
|
|
Postal/Zip Code: |
|
|
Country: |
|
|
Phone Number: |
|
|
Fax Number: |
|
|
Please fax this form to:
(646) 607-1907 or (646) 964-6609 (from USA)
+353-1-481-1716 or +353-1-653-1571 (from Rest of World)
|
|
Page 2 of 2
Printed 28/11/2009 19:19:51
|
|
Payment information
Please indicate the payment method you would like to use by selecting the appropriate
box.
|
|
|
|
|
American Express
|
|
|
Diners Club
|
|
|
Master Card
|
|
|
Visa
|
|
|
|
|
|
|
Cardholder's Name: |
|
|
|
|
Cardholder's Signature: |
|
|
|
|
Expiry Date: |
/ |
|
|
|
Card Number: |
|
|
|
|
CVV Security Code: |
|
|
|
|
Issue Date: |
/ (Diners
Club only)
|
|
|
|
|
|
|
Please post the check, accompanied by this form, to:
Research and Markets,
Guinness Centre,
Taylors Lane,
Dublin 8,
Ireland.
|
|
|
|
|
|
|
Please transfer funds to:
|
|
|
Account number: |
83313083 |
|
Sort code: |
98-53-30 |
|
Swift code: |
ULSBIE2D |
|
IBAN number: |
IE78ULSB98533083313083 |
|
Bank Address: |
Ulster Bank,
27-35 Main St,
Blackrock,
Co. Dublin,
Ireland. |
|
|
|
If you have a Marketing Code please enter it below:
|
|
|
Marketing Code: |
|
|
Please note that by ordering from Research and Markets you are agreeing to our Terms and Conditions at http://www.researchandmarkets.com/info/terms.asp
|
|
Please fax this form to:
(646) 607-1907 or (646) 964-6609 (from USA)
+353-1-481-1716 or +353-1-653-1571 (from Rest of World)
|
|
|
|
|
|
